Tag: Novartis

Dr. Reddy’s to sell and distribute certain Novartis’ products in India

businessnewstoday- February 11, 2022 0

Dr. Reddy's Laboratories has signed an exclusive sales and distribution agreement with Novartis India Limited (NIL) for the latter’s Voveran range, the Calcium range and ... Read More

Novartis to acquire ocular gene therapy company Gyroscope Therapeutics

businessnewstoday- January 3, 2022 0

Novartis has agreed to acquire Gyroscope Therapeutics, a UK-based ocular gene therapy company, in a deal worth up to $1.5 billion. As per the terms ... Read More

Novartis gets Leqvio FDA approval for reducing bad cholesterol levels

businessnewstoday- January 2, 2022 0

Novartis has secured approval from the US Food and Drug Administration (FDA) for its small interfering RNA (siRNA) therapy Leqvio (inclisiran) for its use in ... Read More

Cipla gets FDA approval for generic version of Novartis’ Durezo

businessnewstoday- August 12, 2021 0

Cipla Limited said that it has secured final approval for its abbreviated new drug application (ANDA) for Difluprednate Ophthalmic Emulsion 0.05% from the US Food ... Read More

Sandoz to acquire GSK’s cephalosporin antibiotics business in $500m worth deal

pharmanewsdaily- February 13, 2021 0

Sandoz, a division of Swiss pharma giant Novartis, has agreed to acquire GSK’s cephalosporin antibiotics business in a deal worth up to $500 million. The ... Read More

Novartis to acquire neuroscience company Cadent Therapeutics in $770m worth deal

pharmanewsdaily- December 19, 2020 0

Novartis acquisition of Cadent Therapeutics : Swiss pharma giant Novartis has agreed to acquire a US neuroscience company Cadent Therapeutics, in a deal worth up ... Read More

Novartis acquires optogenetics gene therapy company Vedere Bio

pharmanewsdaily- October 29, 2020 0

Novartis acquisition of Vedere Bio : US-based stealth-stage company Vedere Bio has been acquired by Swiss pharma giant Novartis in a deal worth up to ... Read More

Novartis reports positive results for Aimovig in phase 2 episodic migraine trial

pharmanewsdaily- October 4, 2020 0

Novartis said that a five-year phase 2 clinical trial of migraine prevention drug Aimovig (erenumab-aooe) has delivered strong long-term safety and efficacy results in patients ... Read More

BioNTech to acquire Novartis’ Marburg manufacturing plant to expand production of COVID-19 vaccine candidates

pharmanewsdaily- September 18, 2020 0

Biopharmaceutical New Technologies (BioNTech) has agreed to acquire a GMP certified manufacturing facility in Marburg, Germany from Novartis to expand the production capacity of its ... Read More

Novartis bags Kesimpta FDA approval for relapsing forms of MS

pharmanewsdaily- August 21, 2020 0

Kesimpta FDA approval for RMS: Novartis has bagged approval from the US Food and Drug Administration (FDA) for its blood cancer drug Kesimpta (ofatumumab, formerly OMB157) ... Read More